SCHEMBL4756006

SCHEMBL4756006

CCc1cnc(NC(=O)c2cccc(OS(=O)(=O)CC(C)(C)C)c2)s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCD O00767 5/20 0.51
SMN1; SMN2 Q16637 7/20 0.46
NPC1 O15118 6/20 0.46
RAB9A P51151 6/20 0.46
ALDH1A1 P00352 5/20 0.46
TP53 P04637 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
TSHR P16473 1/20 0.46
HPGD P15428 3/20 0.44
KDM4E B2RXH2 2/20 0.43
GLA P06280 1/20 0.43
POLB P06746 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CCNE1 P24864 1/20 0.43
CDK2 P24941 1/20 0.43
CDK5 Q00535 1/20 0.43
GAA P10253 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
LMNA P02545 1/20 0.42
PPARG P37231 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756254 0.79 ALDH1A1 (0.34) SCDALDH1A1TSHRCCNE1CDK2
SCHEMBL4755989 0.79 SMN1; SMN2 (0.48) SCDSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL4756089 0.78 SCD (0.52) SCDSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL8594861 0.76 ALDH1A1 (0.57) SCDSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL7382010 0.75 ALDH1A1 (0.53) SCDSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL11919154 0.74 ALDH1A1 (0.70) SCDSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL4756132 0.72 CCNE1 (0.63) SCDSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL4755961 0.72 NPC1 (0.48) SCDSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL4756065 0.71 SMN1; SMN2 (0.50) SCDSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL13081833 0.71 SCD (0.56) SCDSMN1; SMN2NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
WO-2009035788-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. (US) 2009-03-19 WO disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC SCD 1845/4885SMN1; SMN2 3410/4885NPC1 585/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC SCD 1845/4885SMN1; SMN2 3410/4885NPC1 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.